Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you've just given your weekly injection and noticed the pen still has liquid in it, you're not alone. Each Mounjaro KwikPen contains four pre-set weekly doses, and because the device delivers only what's programmed for each injection, some fluid almost always remains in the barrel after the final dose. That leftover is there by design — it is not a missed dose, and you should not attempt to use it. These are prescription-only medicines; your prescriber and the NHS tirzepatide medicines guide are the right places to turn if anything about your pen's behaviour is unexpected.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: it's Sunday evening, your usual injection day. You press the button, hold for ten seconds, withdraw the needle, and glance at the pen. There's still a noticeable amount of liquid in there. The instinct is to wonder whether you did something wrong, or whether you've wasted part of your medicine.
You haven't. Mounjaro KwikPens are manufactured with a deliberate overfill, a buffer of fluid built into every cartridge to ensure that each of the four programmed doses is delivered in full, even accounting for small variations in the dispensing mechanism. The device releases a precise, fixed volume per activation. Once the fourth dose has been given, the pen reaches its end-of-use point and the mechanism locks. If you'd like to understand why there is a dose left in your Mounjaro pen, we cover the full explanation of that overfill and what it means for your treatment.
This is covered clearly in the Mounjaro Patient Information Leaflet, and the NHS tirzepatide page notes that the pen contains enough medicine for four injections. If you're curious about the exact mechanics of how many doses your pen holds, our page on the four-dose pen design goes into more detail.
The liquid level alone is a poor guide. The indicator window (the small viewing area on the side of the KwikPen) and the device's dose counter or locking behaviour are what actually tell you where you stand.
On a fresh pen, the first dose is available and the window shows the starting position. After each successful injection, the counter or indicator advances. When the fourth dose has been delivered, the KwikPen will not activate again: the plunger locks and the button will not depress fully. If your pen still activates and delivers medication, you have doses remaining. If it has locked, you don't, regardless of any fluid still visible.
Some people notice what looks like a fifth dose's worth of fluid and wonder whether the pen was overfilled beyond its labelled count. Our page on whether a Mounjaro pen can contain five doses addresses that question directly. The short answer: the pen is labelled for four injections, and that's what you should count on.
If you're genuinely uncertain whether a dose was delivered fully (perhaps the needle wasn't inserted properly, or you didn't hear or feel the expected click) the right call is to contact your prescriber before injecting again. Taking a double dose is not the answer. Your prescriber can walk you through what happened and advise on next steps based on your specific situation.
A finished KwikPen should go into a sharps bin, not a household bin or recycling. If you don't yet have a sharps container, your local pharmacy can usually supply one or advise where to get one; you can also pick one up from our sharps container if you'd like one sent with your next order.
Timing matters here, too. If your next pen is due to arrive on payday, a bank holiday Monday, or during a school holiday week when deliveries feel unpredictable, it's worth planning ahead so you're not left without medication on your injection day. Keep an eye on tracking, and if supply or cost is on your mind, our Mounjaro cost page explains what the price includes and how private treatment is structured.
Storage of your current pen matters just as much as the next one: Mounjaro pens should be kept refrigerated between 2°C and 8°C. For precise guidance on the limited window during which a pen can be kept at room temperature, the Patient Information Leaflet is the definitive source, the window varies and we'd rather you check the leaflet than rely on a general figure stated here.
Occasionally, the question about residual fluid masks a deeper uncertainty: is my dose working? Am I on the right strength? Should I be moving up to the next pen? These are the questions worth bringing to a prescriber, because the answers depend on your individual progress, how well you've tolerated the current dose, and what the clinical picture shows. There's a fuller discussion of how tirzepatide doses are structured on our usual tirzepatide dose page, and our Mounjaro overview covers the licensed strengths from 2.5mg through to 15mg.
Dose decisions are not for the pen to make and not for a website to prescribe. They belong in a clinical conversation. If your current strength isn't feeling right, or you'd like a prescriber to review where you are in your treatment, you're welcome to speak to our prescribers, every review at nume is done by a GPhC-registered Independent Prescriber, reading your notes personally.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.